Related Experiment Video
Updated: Apr 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics
Marta Ibañez-Lligoña1,2,3, Sergi Colomer-Castell1,3,4, Carolina Campos1,3,4
1Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca (VHIR), Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron (IIS IR-HUVH), Barcelona, Spain.
Shotgun metagenomic sequencing (mNGS) shows promise for pathogen detection but faces sensitivity challenges. A new framework improves contamination control and viral genome recovery, crucial for clinical diagnostics, especially in low-biomass samples.
Area of Science:
- Clinical diagnostics
- Genomics
- Infectious disease research
Background:
- Shotgun metagenomic sequencing (mNGS) is a powerful untargeted method for pathogen detection and genome characterization.
- Clinical implementation of mNGS is hindered by contamination and reduced sensitivity, particularly in low-biomass samples.
Purpose of the Study:
- To assess the performance of mNGS in clinical samples for pathogen detection and genome characterization.
- To develop and evaluate a framework for improving contamination management and sensitivity in clinical mNGS.
Main Methods:
- Applied mNGS to 144 clinical samples (chronic, acute, and respiratory co-infections).
- Established a contamination control framework using negative controls, contaminant watchlists, and computational filtering.
- Assessed viral detection and genome recovery across different sample types and viral loads.
Main Results:
- Viral load was the primary determinant of mNGS sensitivity; reliable recovery occurred at higher titers.
- The developed framework significantly improved contamination management, reducing false positives and enhancing viral genome recovery.
- mNGS detected clinically relevant co-infections and refined viral classification, but highlighted risks of spurious detections without proper workflows.
Conclusions:
- Defined practical sensitivity thresholds for clinical mNGS.
- Emphasized the critical need for contamination-aware workflows, especially for low-biomass samples.
- Provided an open-source contaminant watchlist to improve the reliability and utility of clinical metagenomics.
More Related Videos
10:44Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow
Published on: August 15, 2025
09:52A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
Published on: January 10, 2025
Related Concept Videos
Modern Molecular Taxonomy
Genomics
Automated Microbial Diagnostics
MALDI-TOF Mass Spectrometry
Applications of Molecular Taxonomy
Pharmacogenomics: Identification of New Drug Targets